Literature DB >> 19767822

Involvement of a disintegrin and metalloproteinase 10 and 17 in shedding of tumor necrosis factor-alpha.

Atsuhiko Hikita1, Nobuho Tanaka, Shoji Yamane, Yasuko Ikeda, Hiroshi Furukawa, Shigeto Tohma, Ryuji Suzuki, Sakae Tanaka, Hiroyuki Mitomi, Naoshi Fukui.   

Abstract

Tumor necrosis factor-alpha (TNF-alpha) is initially synthesized as a membrane-bound protein and converted into a soluble form by proteolytic cleavage. Although a disintegrin and metalloproteinase 17 (ADAM17) is considered to be the primary sheddase for TNF-alpha, it is not known whether ADAM17 is solely responsible for that process in any type of cells. To identify the TNF-alpha sheddase(s) in varieties of cells, we performed experiments using a unique screening system and observed that ADAM9, ADAM10, ADAM17, and ADAM19 were capable of cleaving TNF-alpha. We then performed RNA interference experiments and confirmed that ADAM10 and ADAM17 were in fact involved in TNF-alpha shedding in 293A cells. In mouse macrophages, ADAM17 was confirmed to be the primary sheddase, but the involvement of ADAM10 was also demonstrated. In NIH3T3 cells, ADAM10 could be more important in the shedding than ADAM17. In mouse vascular endothelial cell line UVfemale2, ADAM10 and ADAM17 were equally involved in TNF-alpha shedding, whereas ADAM17 was a major sheddase in human osteoarthritic chondrocytes. From these observations and others, we concluded that both ADAM10 and ADAM17 can be a TNF-alpha sheddase and that their significance could be determined by their expression levels and the abundance of tissue inhibitor of metalloproteinases.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19767822     DOI: 10.1139/o09-015

Source DB:  PubMed          Journal:  Biochem Cell Biol        ISSN: 0829-8211            Impact factor:   3.626


  25 in total

1.  Prostate cancer cells hyper-activate CXCR6 signaling by cleaving CXCL16 to overcome effect of docetaxel.

Authors:  Neeraj Kapur; Hina Mir; Guru P Sonpavde; Sanjay Jain; Sejong Bae; James W Lillard; Shailesh Singh
Journal:  Cancer Lett       Date:  2019-04-08       Impact factor: 8.679

2.  Impact of serum soluble programed death ligand 1 on end of treatment metabolic response of diffuse large B cell lymphoma patients.

Authors:  Amro Mohamed Sedky El-Ghammaz; Hoda Ahmed Gadallah; Gihan Kamal; Mohammed Magdy Maher; Mohamad Ayed Mohamad
Journal:  Clin Exp Med       Date:  2018-06-06       Impact factor: 3.984

3.  A disintegrin and metalloproteinase-10 (ADAM-10) mediates DN30 antibody-induced shedding of the met surface receptor.

Authors:  Florian Schelter; Julia Kobuch; Marcia L Moss; J David Becherer; Paolo M Comoglio; Carla Boccaccio; Achim Krüger
Journal:  J Biol Chem       Date:  2010-06-16       Impact factor: 5.157

4.  The N-glycome regulates the endothelial-to-hematopoietic transition.

Authors:  Dionna M Kasper; Jared Hintzen; Yinyu Wu; Joey J Ghersi; Hanna K Mandl; Kevin E Salinas; William Armero; Zhiheng He; Ying Sheng; Yixuan Xie; Daniel W Heindel; Eon Joo Park; William C Sessa; Lara K Mahal; Carlito Lebrilla; Karen K Hirschi; Stefania Nicoli
Journal:  Science       Date:  2020-12-03       Impact factor: 47.728

5.  ADAM10 and ADAM17 proteases mediate proinflammatory cytokine-induced and constitutive cleavage of endomucin from the endothelial surface.

Authors:  Jinling Yang; Michelle E LeBlanc; Issahy Cano; Kahira L Saez-Torres; Magali Saint-Geniez; Yin-Shan Ng; Patricia A D'Amore
Journal:  J Biol Chem       Date:  2020-03-19       Impact factor: 5.157

6.  Disintegrin and metalloproteinases (ADAMs) expression in gastroesophageal reflux disease and in esophageal adenocarcinoma.

Authors:  T Kauttu; H Mustonen; S Vainionpää; L Krogerus; I Ilonen; J Räsänen; J Salo; P Puolakkainen
Journal:  Clin Transl Oncol       Date:  2016-03-30       Impact factor: 3.405

7.  Role of prostacyclin signaling in endothelial production of soluble amyloid precursor protein-α in cerebral microvessels.

Authors:  Tongrong He; Anantha Vijay R Santhanam; Tong Lu; Livius V d'Uscio; Zvonimir S Katusic
Journal:  J Cereb Blood Flow Metab       Date:  2015-11-20       Impact factor: 6.200

8.  The presence of high level soluble herpes virus entry mediator in sera of gastric cancer patients.

Authors:  Sook-Kyoung Heo; Seong-A Ju; Gyu Yeol Kim; Sang-Min Park; Sung Hun Back; Neung-Hwa Park; Young Joo Min; Won G An; Thi Thu-Ha Nguyen; Sun-Min Kim; Byung-Sam Kim
Journal:  Exp Mol Med       Date:  2012-02-29       Impact factor: 8.718

Review 9.  Apoptosis-Inducing TNF Superfamily Ligands for Cancer Therapy.

Authors:  Olivia A Diaz Arguello; Hidde J Haisma
Journal:  Cancers (Basel)       Date:  2021-03-27       Impact factor: 6.639

Review 10.  RANKL cytokine: from pioneer of the osteoimmunology era to cure for a rare disease.

Authors:  Nadia Lo Iacono; Alessandra Pangrazio; Mario Abinun; Robbert Bredius; Marco Zecca; Harry C Blair; Paolo Vezzoni; Anna Villa; Cristina Sobacchi
Journal:  Clin Dev Immunol       Date:  2013-05-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.